Filters
National penalties for breach of medical device advertising rules
Penalties for breaching advertising laws for medical devices or IVDs in Europe include administrative fines, criminal fines, and damages for unfair competition, but with huge variation between countries. Compliance with local laws is crucial to avoid sanctions and third party damages claims.
3 / 4 观点
Taking care around use of social media for medicines companies
Pharmaceutical companies must exercise caution when using social media for advertising in Europe. Compliance with diverse national laws, transparency in promotional activities, and careful planning are essential.
4 / 4 观点
Beginner's guide to medicines advertising in Europe
Regulatory oversight in Europe strictly governs pharmaceutical advertising, including content, presentation, and audience, although with some variation between countries. Compliance with these regulations is essential to avoid sanctions and third-party damages claims.
2 / 4 观点
Can medical devices be advertised on social media in Europe?
Advertising medical devices on social media in Europe is complex, requiring compliance with diverse national regulations and careful planning to avoid legal pitfalls.
1 / 4 观点
DEFRA user survey: share your feedback on the Nagoya Compliance Regulations 2015
Changes to the privilege rules between companies and shareholders
EU consumer law in 2025 – good for consumers, tough on lawyers?
Nathalie Koch looks at the European Commission's plans for a Digital Fairness Act and at what that means for the EU consumer protection landscape in 2025.
7 / 7 观点
What will the UK government do for tech and digital in 2025?
Debbie Heywood looks at the new(ish) Labour government's tech and digital policy for 2025 and at what to expect.
4 / 7 观点
Life online in 2025 – safer how?
Michael Szlesinger predicts the big trends in online safety in 2025 with a focus on the UK.
2 / 7 观点
DMCC Act – consultation on the implementation of the new subscription contracts regime